Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (341-350 of 636) with videos related to

Pageof 64
Sort By:
JHEP Reports : Innovation in Hepatology|July 21, 2025
Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatideMark L Hartman, Rohit Loomba, Eric J Lawitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2022
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/FirsocostatEric J Lawitz, Bal Raj Bhandari, Peter J Ruane, et al.
Contemporary Clinical Trials|February 25, 2021
RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19Veeral Ajmera, Wesley K Thompson, Davey M Smith, et al.
The American Journal of Gastroenterology|February 5, 2024
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver DiseaseRichard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2024
Dynamic pattern of postprandial bile acids in paediatric non-alcoholic fatty liver diseaseJiating Huang, Hu Lin, A-Na Liu, et al.
Atherosclerosis|February 26, 2017
Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of AtherosclerosisRosemay A Remigio-Baker, Matthew A Allison, Nketi I Forbang, et al.
Radiology. Imaging Cancer|March 29, 2021
Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary ExperienceRyan L Brunsing, Dennis H Chen, Alexandra Schlein, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 30, 2017
MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitisCheng William Hong, Adrija Mamidipalli, Jonathan C Hooker, et al.
Nature Medicine|June 11, 2025
TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trialMazen Noureddin, Naim Alkhouri, Eric J Lawitz, et al.
The Journal of Clinical Investigation|August 9, 2019
Degradation of splicing factor SRSF3 contributes to progressive liver diseaseDeepak Kumar, Manasi Das, Consuelo Sauceda, et al.
Pageof 64

Showing results (341-350 of 636) with videos related to

Sort By:
Pageof 64
JHEP Reports : Innovation in Hepatology|July 21, 2025
Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatideMark L Hartman, Rohit Loomba, Eric J Lawitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2022
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/FirsocostatEric J Lawitz, Bal Raj Bhandari, Peter J Ruane, et al.
Contemporary Clinical Trials|February 25, 2021
RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19Veeral Ajmera, Wesley K Thompson, Davey M Smith, et al.
The American Journal of Gastroenterology|February 5, 2024
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver DiseaseRichard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2024
Dynamic pattern of postprandial bile acids in paediatric non-alcoholic fatty liver diseaseJiating Huang, Hu Lin, A-Na Liu, et al.
Atherosclerosis|February 26, 2017
Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of AtherosclerosisRosemay A Remigio-Baker, Matthew A Allison, Nketi I Forbang, et al.
Radiology. Imaging Cancer|March 29, 2021
Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary ExperienceRyan L Brunsing, Dennis H Chen, Alexandra Schlein, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 30, 2017
MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitisCheng William Hong, Adrija Mamidipalli, Jonathan C Hooker, et al.
Nature Medicine|June 11, 2025
TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trialMazen Noureddin, Naim Alkhouri, Eric J Lawitz, et al.
The Journal of Clinical Investigation|August 9, 2019
Degradation of splicing factor SRSF3 contributes to progressive liver diseaseDeepak Kumar, Manasi Das, Consuelo Sauceda, et al.
Pageof 64